A firm fixed price purchase order is intended to be sole sourced to Diagnostic Laboratory Services, Inc. for specimen analytical and reference laboratory testing services at the US Naval Hospital Guam. The services include high-volume blood tests, genetic testing, and microbiology, with CLIA and CAP accreditation requirements that only DLS is said to meet given the hospital’s remote location. The base period of performance is 10/19/2026 through 10/18/2027, with four one-year options extending through 10/18/2031. This notice is not a request for competitive quotes, and no solicitation exists, but interested parties may submit a capability statement for the government’s consideration.